Magnus Nilsson

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

M. Lowery, G. Piessen, R. Turkington, 2023, The lancet. Gastroenterology & hepatology.

Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.

L. Lundell, W. Ye, M. Nilsson, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.

A. Viste, S. Friesland, L. Lundell, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Fit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus.

G. Nieuwenhuijzen, M. Luyer, C. Palanivelu, 2020, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.

S. Friesland, N. Nielsen, L. Lundell, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.